Core Points - The company, Heart Company (02400), announced the issuance of 800 ordinary shares on October 6, 2025, due to eligible participants exercising stock options under the stock option plan adopted on June 25, 2021 [1] Summary by Category - **Company Announcement** - Heart Company issued 800 ordinary shares as a result of the exercise of stock options by eligible participants [1] - The stock option plan was adopted on June 25, 2021, indicating a structured approach to incentivizing employees or stakeholders [1] - **Future Implications** - The issuance of shares may impact the company's capital structure and shareholder equity moving forward [1] - This action reflects the company's ongoing commitment to its stock option plan and employee engagement strategies [1]

Group 1 - The existing share option plan of Jia Rui International (00822) was adopted on May 19, 2017, and is valid for ten years from the adoption date [1] - As of the announcement date, there are 36.96 million share options granted under the existing plan that have not yet been exercised [1] - The board intends not to grant any further share options under the existing plan until the special shareholders' meeting is held [1] Group 2 - The company proposes to adopt a new share award plan in accordance with the latest regulations under Chapter 17 of the listing rules [2] - The purpose of the new share award plan is to provide eligible participants with opportunities to acquire ownership interests in the company and to encourage them to enhance the value of the company and its shares [2] - The new plan aims to benefit the company and its shareholders overall and to incentivize eligible participants to contribute to the success of the group’s business [2]

Core Viewpoint - The company is proposing a new share option plan to replace the existing one, which was adopted in May 2017 and has a validity of ten years. The new plan aims to provide eligible participants with opportunities to acquire ownership interests in the company and to encourage their commitment to enhancing the company's value, benefiting both the company and its shareholders [1][2]. Group 1 - The existing share option plan allows the company to terminate it at any time through a resolution at a shareholders' meeting, but any options granted before termination will remain valid and exercisable [1]. - As of the announcement date, there are 36.96 million share options granted under the existing plan that have not yet been exercised [1]. - The board has no intention to grant any further share options under the existing plan until the special shareholders' meeting is held [1]. Group 2 - The new share award plan is proposed in accordance with the latest regulations under Chapter 17 of the listing rules, aiming to provide eligible participants with opportunities to acquire ownership interests in the company [2]. - The new plan is designed to encourage eligible participants to enhance the company's and its shares' value, thereby benefiting the company and its shareholders overall [2].

Core Points - The 2012 share option plan adopted by the company has expired on December 5, 2022, marking its ten-year anniversary [1] - After the expiration of the 2012 share option plan, no further share options can be presented or granted [1] - As of the announcement date, there are a total of 10 million share options that remain unexercised, which will continue to be valid and exercisable within the specified exercise period of the 2012 plan [1] - The board of directors recommends adopting a new share option plan in accordance with Listing Rule Chapter 17 to incentivize or reward participants for their contributions or potential contributions to the group's growth and development [1]

Core Viewpoint - The company announced the expiration of its 2012 share option plan, which was adopted on December 6, 2012, and reached its ten-year mark on December 5, 2022, after which no further options can be presented or granted [1] Summary by Sections - The 2012 share option plan had a total of 10 million options that remain unexercised as of the announcement date, which will continue to be valid and exercisable within the specified exercise period [1] - The board of directors proposed to adopt a new share option plan in accordance with Listing Rule Chapter 17, aimed at providing incentives or rewards for participants based on their contributions or potential contributions to the group's growth and development [1]

Core Viewpoint - China Jinshi (01380) announced the cancellation of previously planned stock options due to insider information regulations, with a new grant of 4.89 million stock options planned for September 29, 2025, pending acceptance by the grantees [1] Group 1 - The company is subject to listing rules that prohibit granting options or incentives after becoming aware of insider information until the information is publicly disclosed [1] - The board decided to cancel the originally planned stock options as they had not been accepted by the relevant grantees [1] - A total of 4.89 million stock options will be re-granted to the same group of grantees, representing approximately 1.32% of the total shares issued as of the announcement date, contingent upon acceptance by the grantees [1]

Core Viewpoint - China Jinshi (01380) announced the grant of stock options to several qualified individuals, allowing the subscription of a total of 4.89 million ordinary shares, representing approximately 1.32% of the total issued shares as of the announcement date [1] Summary by Relevant Sections - **Stock Option Grant**: The company has granted stock options under its stock option plan adopted on June 29, 2020, prior to the new regulations effective January 1, 2023 [1] - **Share Details**: The stock options are for ordinary shares with a par value of HKD 0.01 each [1] - **Impact on Issued Shares**: The total shares granted will account for about 1.32% of the company's total issued shares as of the announcement date [1]

Core Viewpoint - Kintor Pharmaceutical Co., Ltd. announced the granting of stock options and restricted share units to incentivize employees and align their interests with the company's and shareholders' best interests [1] Group 1: Stock Options - The company granted 6.7405 million stock options to 348 option grantees on September 18, 2025, pending acceptance by the grantees [1] - The purpose of granting stock options is to reward employees for their past contributions to the company's success and encourage further contributions [1] Group 2: Restricted Share Units - The company also granted 1.9115 million restricted share units to 196 grantees on September 18, 2025, which is subject to acceptance by the grantees [1] - The aim of granting restricted share units is to align the interests of eligible individuals with the group's interests, encouraging retention and contributions to long-term growth and profitability [1]

Core Viewpoint - The company, Gilead Sciences-B (01672), announced the issuance of 98,000 ordinary shares due to eligible participants exercising stock options under the stock option plan adopted on June 6, 2019 [1] Group 1 - The total number of ordinary shares to be issued is 98,000 [1] - The stock option plan was adopted on June 6, 2019 [1] - The issuance date for the shares is set for September 10, 2025 [1]

Group 1 - The company, Neway Group (01686), announced the issuance of 20,000 shares due to the exercise of stock options [1] - The stock options were granted under a stock option plan adopted on November 1, 2022 [1] - The exercise date for the stock options is set for September 10, 2025 [1]